{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:38:33Z","timestamp":1789706313622,"version":"4.0.1"},"reference-count":128,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mehy.2004.08.031","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T12:26:37Z","timestamp":1110543997000},"page":"123-137","source":"Crossref","is-referenced-by-count":27,"title":["Alzheimer\u2019s disease and the \u2018ABSENT\u2019 hypothesis: mechanism for amyloid \u03b2 endothelial and neuronal toxicity"],"prefix":"10.1016","volume":"65","author":[{"given":"Samir","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvi","family":"Rauk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mehy.2004.08.031_bib1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/archneur.59.11.1764","article-title":"Survival following a diagnosis of Alzheimer disease","volume":"59","author":"Brookmeyer","year":"2002","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/geront\/43.2.158","article-title":"Cost of illness of Alzheimer\u2019s disease: how useful are current estimates","volume":"43","author":"Bloom","year":"2003","journal-title":"Gerontologist"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib3","first-page":"CD003154","article-title":"Memantine for dementia","author":"Areosa","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.289.2.210","article-title":"Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis","volume":"289","author":"Trinh","year":"2003","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2004.08.031_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-4328(00)00214-X","article-title":"Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer\u2019s disease","volume":"113","author":"Maelicke","year":"2000","journal-title":"Behav Brain Res"},{"issue":"10","key":"10.1016\/j.mehy.2004.08.031_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4088\/JCP.v61n1001","article-title":"The new cholinesterase inhibitors for Alzheimer\u2019s disease, Part 1: their similarities are different","volume":"61","author":"Stahl","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/jpet.102.045773","article-title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","volume":"305","author":"Samochocki","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.mehy.2004.08.031_bib9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib10","first-page":"95","article-title":"NC-531 (Neurochem)","volume":"5","author":"Geerts","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neurobiolaging.2003.12.020","article-title":"Lessons from the AN 1792 Alzheimer vaccine: lest we forget","volume":"25","author":"Robinson","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2004.08.031_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","article-title":"Alzheimer\u2019s amyloid \u03b2-peptide-associated free radical oxidative stress and neurotoxicity","volume":"130","author":"Varadarajan","year":"2000","journal-title":"J Struct Biol"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jnr.10389","article-title":"Role of mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"70","author":"Castellani","year":"2002","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1016\/j.mehy.2004.08.031_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1179\/016164103101201977","article-title":"Mitochondria and vascular lesions as a central target for the development of Alzheimer\u2019s disease and Alzheimer disease-like pathology in transgenic mice","volume":"25","author":"Aliev","year":"2003","journal-title":"Neurol Res"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.mehy.2004.08.031_bib17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid \u03b2-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer\u2019s disease brain. A review","volume":"36","author":"Butterfield","year":"2002","journal-title":"Free Radic Res"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0197-4580(95)00066-N","article-title":"Are reactive oxygen species involved in Alzheimer\u2019s disease","volume":"16","author":"Benzi","year":"1995","journal-title":"Neurobiol Aging"},{"issue":"12","key":"10.1016\/j.mehy.2004.08.031_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer\u2019s disease brain: central role for amyloid \u03b2-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-2002-4309","article-title":"Amyloid \u03b2-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer\u2019s disease brain exists","volume":"4","author":"Butterfield","year":"2002","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.mehy.2004.08.031_bib21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer\u2019s disease brain: potential causes and consequences involving amyloid \u03b2-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid \u03b2peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"issue":"24","key":"10.1016\/j.mehy.2004.08.031_bib23","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1021\/ja010452r","article-title":"Different mechanisms of oxidative stress and neurotoxicity for Alzheimer\u2019s A \u03b2 (1\u201342) and A \u03b2 (25\u201335)","volume":"123","author":"Varadarajan","year":"2001","journal-title":"J Am Chem Soc"},{"issue":"6","key":"10.1016\/j.mehy.2004.08.031_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1159\/000017195","article-title":"Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer\u2019s disease","volume":"10","author":"Kalman","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.mehy.2004.08.031_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.2000.tb06395.x","article-title":"The renin angiotensin system and Alzheimer\u2019s disease","volume":"903","author":"Amouyel","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.mehy.2004.08.031_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1749-6632.2000.tb06393.x","article-title":"Cardiovascular and other risk factors for Alzheimer\u2019s disease and vascular dementia","volume":"903","author":"Meyer","year":"2000","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000067109","article-title":"Risk factors for dementia in the cardiovascular health cognition study","volume":"22","author":"Kuller","year":"2003","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch Neurol"},{"issue":"Suppl. 4","key":"10.1016\/j.mehy.2004.08.031_bib29","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0197-4580(97)00063-8","article-title":"Comparison of neuropathologic criteria for the diagnosis of Alzheimer\u2019s disease","volume":"18","author":"Geddes","year":"1997","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s004010051163","article-title":"Clinical validity of Braak neuropathological staging in the oldest-old","volume":"99","author":"Gold","year":"2000","journal-title":"Acta Neuropathol (Berl)"},{"issue":"12","key":"10.1016\/j.mehy.2004.08.031_bib31","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1212\/01.WNL.0000069923.64550.9F","article-title":"Education modifies the relation of AD pathology to level of cognitive function in older persons","volume":"60","author":"Bennett","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0163-7258(96)00116-7","article-title":"Cerebral vessels in ageing and Alzheimer\u2019s Disease","volume":"72","author":"Kalaria","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.mehy.2004.08.031_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(02)00256-3","article-title":"Similarities between Alzheimer\u2019s disease and vascular dementia","volume":"203\u2013204","author":"Kalaria","year":"2002","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0197-4580(00)00111-1","article-title":"Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer\u2019s pathogenesis","volume":"21","author":"de la Torre","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2004.08.031_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1749-6632.2000.tb06394.x","article-title":"Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer\u2019s disease","volume":"903","author":"de la Torre","year":"2000","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib36","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","article-title":"Alzheimer disease as a vascular disorder: nosological evidence","volume":"33","author":"de la Torre","year":"2002","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000077737","article-title":"CT brain findings in clinical dementia investigation \u2013 underestimation of mixed dementia","volume":"18","author":"Nagga","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","article-title":"Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology \u2013 a pilot study","volume":"107","author":"Attems","year":"2004","journal-title":"Acta Neuropathol (Berl)"},{"issue":"5-6","key":"10.1016\/j.mehy.2004.08.031_bib39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: an update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J Neural Transm"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-004-0822-6","article-title":"Amyloid \u03b2 peptide 1\u201342 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology","volume":"107","author":"Attems","year":"2004","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000079192","article-title":"Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia","volume":"18","author":"Haglund","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.mehy.2004.08.031_bib42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is AD neurodegenerative or vascular","volume":"3","author":"de la Torre","year":"2004","journal-title":"The Lancet [Neurology]"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(04)00674-X","article-title":"A diagnostic dilemma: is \u201cAlzheimer\u2019s dementia Alzheimer\u2019s disease, vascular dementia, or both","volume":"3","author":"Roman","year":"2004","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.mehy.2004.08.031_bib44","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archneur.60.12.1707","article-title":"Stroke and the risk of Alzheimer disease","volume":"60","author":"Honig","year":"2003","journal-title":"Arch Neurol"},{"issue":"18","key":"10.1016\/j.mehy.2004.08.031_bib45","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"Systolic hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11906-004-0070-0","article-title":"Prevention of dementia and cerebroprotection with antihypertensive drugs","volume":"6","author":"Hanon","year":"2004","journal-title":"Curr Hypertens Rep"},{"issue":"1-2","key":"10.1016\/j.mehy.2004.08.031_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000073981","article-title":"Association between statin use and Alzheimer\u2019s disease","volume":"23","author":"Zamrini","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mehy.2004.08.031_bib48","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1749-6632.2002.tb04851.x","article-title":"Treatment of Alzheimer\u2019s disease by transposition of the omentum","volume":"977","author":"Goldsmith","year":"2002","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"10.1016\/j.mehy.2004.08.031_bib49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1179\/016164103101201922","article-title":"Omental transposition to the brain as a surgical method for treating Alzheimer\u2019s disease","volume":"25","author":"Goldsmith","year":"2003","journal-title":"Neurol Res"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib50","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","article-title":"Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate Abeta1\u201342\/1\u201340 ratio in vitro and in vivo","volume":"17","author":"Borchelt","year":"1996","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1006\/bbrc.1998.8186","article-title":"Early glycoxidation damage in brains from Down\u2019s syndrome","volume":"243","author":"Odetti","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.mehy.2004.08.031_bib52","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0891-5849(02)01049-3","article-title":"Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer\u2019s patients","volume":"33","author":"Cecchi","year":"2002","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/exnr.1999.7086","article-title":"Entorhinal cortex \u03b2-amyloid load in individuals with mild cognitive impairment","volume":"158","author":"Mufson","year":"1999","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JAD-2001-3206","article-title":"The severity of cortical Alzheimer\u2019s type changes is positively correlated with increased amyloid-\u03b2Levels:Resolubilization of amyloid-\u03b2with transition metal ion chelators","volume":"3","author":"Fonte","year":"2001","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00401-001-0493-5","article-title":"Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly","volume":"103","author":"Zekry","year":"2002","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000071006","article-title":"The validity and reliability of 6 sets of clinical criteria to classify Alzheimer\u2019s disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach","volume":"16","author":"Hogervorst","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.STR.0000054050.51530.76","article-title":"Converging pathogenic mechanisms in vascular and neurodegenerative dementia","volume":"34","author":"Iadecola","year":"2003","journal-title":"Stroke"},{"issue":"4-5","key":"10.1016\/j.mehy.2004.08.031_bib58","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1023\/A:1025092617651","article-title":"Cerebrovascular effects of amyloid-\u03b2peptides: mechanisms and implications for Alzheimer\u2019s dementia","volume":"23","author":"Iadecola","year":"2003","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"10.1016\/j.mehy.2004.08.031_bib59","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.ATV.0000102660.99744.85","article-title":"Atherosclerosis and neurodegeneration: unexpected conspirators in Alzheimer\u2019s dementia","volume":"23","author":"Iadecola","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/exnr.1997.6743","article-title":"Characteristics of the in vitro vasoactivity of \u03b2-amyloid peptides","volume":"150","author":"Crawford","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.mehy.2004.08.031_bib62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1749-6632.2000.tb06363.x","article-title":"A \u03b2vasoactivity in vivo","volume":"903","author":"Suo","year":"2000","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"10.1016\/j.mehy.2004.08.031_bib63","doi-asserted-by":"crossref","first-page":"H2417","DOI":"10.1152\/ajpheart.2001.281.6.H2417","article-title":"A \u03b2-peptides enhance vasoconstriction in cerebral circulation","volume":"281","author":"Niwa","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib64","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1179\/016164101101198758","article-title":"Physiological levels of \u03b2-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production","volume":"23","author":"Price","year":"2001","journal-title":"Neurol Res"},{"issue":"6","key":"10.1016\/j.mehy.2004.08.031_bib65","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1179\/016164103101201940","article-title":"Vasoactive effects of A \u03b2in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer\u2019s disease: role of inflammation","volume":"25","author":"Paris","year":"2003","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1179\/016164104225014003","article-title":"Aging enhances vascular dysfunction induced by the Alzheimer\u2019s peptide \u03b2-amyloid","volume":"26","author":"Price","year":"2004","journal-title":"Neurol Res"},{"key":"10.1016\/j.mehy.2004.08.031_bib67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1749-6632.1997.tb48513.x","article-title":"The effect of stepwise cerebral hypoperfusion on energy metabolism and amyloid precursor protein (APP) in cerebral cortex and hippocampus in the adult rat","volume":"826","author":"Plaschke","year":"1997","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0197-4580(00)00131-7","article-title":"Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion","volume":"21","author":"Bennett","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)02113-7","article-title":"Hypoperfusion induces over expression of \u03b2-amyloid precursor protein mRNA in a focal ischemic rodent model","volume":"853","author":"Shi","year":"2000","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.mehy.2004.08.031_bib70","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0165-6147(00)01866-6","article-title":"Cerebrovascular structure and dementia: new drug targets","volume":"22","author":"Atkinson","year":"2001","journal-title":"Trends Pharmacol Sci"},{"issue":"6171","key":"10.1016\/j.mehy.2004.08.031_bib71","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/bmj.1.6171.1117","article-title":"Failure of cerebral autoregulation as a cause of brain dysfunction in the elderly","volume":"1","author":"Wollner","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.mehy.2004.08.031_bib72","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0197-4580(00)00125-1","article-title":"The role of cerebral ischemia in Alzheimer\u2019s disease","volume":"21","author":"Kalaria","year":"2000","journal-title":"Neurobiology of Aging"},{"issue":"22","key":"10.1016\/j.mehy.2004.08.031_bib73","first-page":"870","article-title":"Increased intracranial arterial resistance in patients with type 2 diabetes mellitus","volume":"113","author":"Tkac","year":"2001","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0006-2952(97)00062-2","article-title":"Reactive oxygen species and Alzheimer\u2019s disease","volume":"54","author":"Multhaup","year":"1997","journal-title":"Biochem Pharmacol"},{"issue":"24","key":"10.1016\/j.mehy.2004.08.031_bib75","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.2174\/0929867033456422","article-title":"Amyloid \u03b2-peptide [1\u201342]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer\u2019s disease brain: mechanisms and consequences","volume":"10","author":"Butterfield","year":"2003","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00001756-200301200-00030","article-title":"Abeta levels in serum, CSF and brain, and cognitive deficits in APP+PS1 transgenic mice","volume":"14","author":"Liu","year":"2003","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejphar.2004.03.001","article-title":"S-Allylcysteine prevents amyloid-\u03b2peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits","volume":"489","author":"Perez-Severiano","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2004.08.031_bib78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-510X(02)00289-7","article-title":"Microvascular damage and platelet abnormalities in early Alzheimer\u2019s disease","volume":"203\u2013204","author":"Borroni","year":"2002","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2004.08.031_bib79","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10072-004-0204-9","article-title":"A \u03b2-related cerebral amyloid angiopathy","volume":"25","author":"Bugiani","year":"2004","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neurobiolaging.2004.02.003","article-title":"Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer\u2019s disease. Pro-CAA position statement","volume":"25","author":"Nicoll","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"6570","key":"10.1016\/j.mehy.2004.08.031_bib81","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/380168a0","article-title":"Beta-amyloid-mediated vasoactivity and vascular endothelial damage","volume":"380","author":"Thomas","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib82","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/excr.1996.3440","article-title":"Beta-amyloid-induced endothelial necrosis and inhibition of nitric oxide production","volume":"230","author":"Sutton","year":"1997","journal-title":"Exp Cell Res"},{"issue":"6","key":"10.1016\/j.mehy.2004.08.031_bib83","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/(SICI)1097-4547(19981215)54:6<828::AID-JNR11>3.0.CO;2-M","article-title":"Endothelial cell dysfunction in response to intracellular over expression of amyloid precursor protein","volume":"4","author":"Jahroudi","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mehy.2004.08.031_bib84","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1749-6632.1998.tb11240.x","article-title":"Enhancement of systemic and pulmonary vasoconstriction by \u03b2-amyloid peptides and its suppression by vasoactive intestinal peptide","volume":"865","author":"Said","year":"1998","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5715","article-title":"SOD1 rescues cerebral endothelial dysfunction in mice over expressing amyloid precursor protein","volume":"2","author":"Iadecola","year":"1999","journal-title":"Nat Neurosci"},{"issue":"17","key":"10.1016\/j.mehy.2004.08.031_bib86","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.1073\/pnas.97.17.9735","article-title":"Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation","volume":"97","author":"Niwa","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.mehy.2004.08.031_bib87","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00004647-200012000-00005","article-title":"Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein over expression in mice","volume":"20","author":"Niwa","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.mehy.2004.08.031_bib88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.2002.tb04799.x","article-title":"Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature","volume":"977","author":"Townsend","year":"2002","journal-title":"Ann NY Acad Sci"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib89","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1046\/j.1471-4159.1997.68051870.x","article-title":"Amyloid \u03b2-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells","volume":"68","author":"Blanc","year":"1997","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(98)00622-3","article-title":"Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats","volume":"253","author":"Jancso","year":"1998","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/nbdi.2001.0460","article-title":"Alterations in cerebral blood flow and glucose utilization in mice over expressing the amyloid precursor protein","volume":"9","author":"Niwa","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib92","doi-asserted-by":"crossref","first-page":"H315","DOI":"10.1152\/ajpheart.00022.2002","article-title":"Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein","volume":"283","author":"Niwa","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"24","key":"10.1016\/j.mehy.2004.08.031_bib93","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/bi990438f","article-title":"The A \u03b2peptide of Alzheimer\u2019s disease directly produces hydrogen peroxide through metal ion reduction","volume":"38","author":"Huang","year":"1999","journal-title":"Biochemistry"},{"issue":"52","key":"10.1016\/j.mehy.2004.08.031_bib94","doi-asserted-by":"crossref","first-page":"37111","DOI":"10.1074\/jbc.274.52.37111","article-title":"Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction","volume":"274","author":"Huang","year":"1999","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.mehy.2004.08.031_bib95","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1046\/j.1432-1327.2001.02248.x","article-title":"Oxidative and hydrolytic properties of \u03b2-amyloid","volume":"268","author":"Brzyska","year":"2001","journal-title":"Eur J Biochem"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib96","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.freeradbiomed.2003.11.004","article-title":"Cupric-amyloid \u03b2peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical","volume":"36","author":"Dikalov","year":"2004","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib97","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0197-4580(95)00095-V","article-title":"Beta amyloid is neurotoxic in hippocampal slice cultures","volume":"16","author":"Harrigan","year":"1995","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib98","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1021673703129","article-title":"Molecular manipulations of extracellular superoxide dismutase: functional importance for learning","volume":"28","author":"Levin","year":"1998","journal-title":"Behav Genet"},{"issue":"23","key":"10.1016\/j.mehy.2004.08.031_bib99","doi-asserted-by":"crossref","first-page":"20466","DOI":"10.1074\/jbc.M100175200","article-title":"Alzheimer\u2019s disease amyloid-\u03b2 binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits","volume":"276","author":"Curtain","year":"2001","journal-title":"J Biol Chem"},{"issue":"43","key":"10.1016\/j.mehy.2004.08.031_bib100","doi-asserted-by":"crossref","first-page":"40302","DOI":"10.1074\/jbc.M206428200","article-title":"Metalloenzyme-like activity of Alzheimer\u2019s disease \u03b2-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2)","volume":"277","author":"Opazo","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2004.08.031_bib101","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1021\/ja994436u","article-title":"Is Oxidative Damage By Beta Amyloid and Prion Peptides Mediated by Hydrogen Atom Transfer from Glycine Alpha-Carbon to Methionine Sulfur within Beta-Sheets","volume":"122","author":"Rauk","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mehy.2004.08.031_bib102","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1021\/ja9939688","article-title":"Influence of the \u03b2-sheet structure on the susceptibility of proteins to backbone oxidative damage: preference for alpha-C centered radical formation at glycine in anti-parallel \u03b2-sheets","volume":"122","author":"Rauk","year":"2000","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib103","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JAD-2002-4403","article-title":"The radical model of Alzheimer\u2019s disease: specific recognition of Gly29 and Gly33 by Met35 in a \u03b2-sheet model of Abeta:an ONIOM study","volume":"4","author":"Brunelle","year":"2002","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib104","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/nbdi.2000.0313","article-title":"\u03b2-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress","volume":"7","author":"Brera","year":"2000","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(02)03218-3","article-title":"Inhibition of amyloid-\u03b2-induced cell death in human brain pericytes in vitro","volume":"952","author":"Rensink","year":"2002","journal-title":"Brain Res"},{"issue":"44","key":"10.1016\/j.mehy.2004.08.031_bib106","doi-asserted-by":"crossref","first-page":"42959","DOI":"10.1074\/jbc.M305494200","article-title":"Neurotoxic, redox-competent Alzheimer\u2019s \u03b2-amyloid is released from lipid membrane by methionine oxidation","volume":"278","author":"Barnham","year":"2003","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"10.1016\/j.mehy.2004.08.031_bib107","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/0264-6021:3440293","article-title":"Amyloid-\u03b2binds catalase with high affinity and inhibits hydrogen peroxide breakdown","volume":"344","author":"Milton","year":"1999","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib108","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1046\/j.1471-4159.1996.67041595.x","article-title":"Amyloid \u03b2-mediated oxidative and metabolic stress in rat cortical neurons: no direct evidence for a role for H2O2 generation","volume":"67","author":"Zhang","year":"1996","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib109","first-page":"1075","article-title":"Clinically important factors influencing endothelial function","volume":"7","author":"Vapaatalo","year":"2001","journal-title":"Med Sci Monit"},{"issue":"11","key":"10.1016\/j.mehy.2004.08.031_bib110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/01.RES.0000020401.61826.EA","article-title":"Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function","volume":"90","author":"Csiszar","year":"2002","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.mehy.2004.08.031_bib111","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1046\/j.1523-1755.2001.0590051859.x","article-title":"The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes","volume":"59","author":"Schnackenberg","year":"2001","journal-title":"Kidney Int"},{"issue":"1-2","key":"10.1016\/j.mehy.2004.08.031_bib112","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(01)01566-7","article-title":"Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats","volume":"436","author":"Nassar","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib113","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1139\/y04-010","article-title":"Tempol improves vascular function in the mesenteric vascular bed of senescent rats","volume":"82","author":"Tatchum-Talom","year":"2004","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib114","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0891-5849(94)E0134-5","article-title":"Cytotoxic effects of autoxidative glycation","volume":"18","author":"Carubelli","year":"1995","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/bbrc.1998.8401","article-title":"The generation of superoxide anions in glycation reactions with sugars, osones, and 3- deoxyosones","volume":"245","author":"Ortwerth","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib116","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/tx980209e","article-title":"Superoxide free radical generation by Amadori compounds: the role of acyclic forms and metal ions","volume":"12","author":"Mossine","year":"1999","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib117","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00125-003-1056-1","article-title":"Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature","volume":"46","author":"Rodriguez-Manas","year":"2003","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib118","first-page":"232","article-title":"Glycoxidation:the menace of diabetes and aging","volume":"70","author":"Vlassara","year":"2003","journal-title":"Mt Sinai J Med"},{"issue":"5 Pt 1","key":"10.1016\/j.mehy.2004.08.031_bib119","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/01.CIR.88.5.2111","article-title":"Interference of glycosylated human hemoglobin with endothelium-dependent responses","volume":"88","author":"Rodriguez-Manas","year":"1993","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0306-3623(98)00251-1","article-title":"Impairment of endothelial relaxations by glycosylated human oxyhemoglobin depends on the oxidative state of the heme group","volume":"32","author":"Angulo","year":"1999","journal-title":"Gen Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2004.08.031_bib121","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001250050011","article-title":"Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels","volume":"43","author":"Vallejo","year":"2000","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.mehy.2004.08.031_bib122","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00392-004-0075-3","article-title":"Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases","volume":"93","author":"Stanger","year":"2004","journal-title":"Z Kardiol"},{"issue":"2","key":"10.1016\/j.mehy.2004.08.031_bib123","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.ATV.20.2.422","article-title":"Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta:role for superoxide anions","volume":"20","author":"Lang","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.mehy.2004.08.031_bib124","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00125-002-0888-4","article-title":"Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits","volume":"45","author":"Shukla","year":"2002","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.mehy.2004.08.031_bib125","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.ATV.0000061735.85377.40","article-title":"Increased superoxide production in coronary arteries in hyperhomocysteinemia:role of tumor necrosis factor-alpha, NAD (P)H oxidase, and inducible nitric oxide synthase","volume":"23","author":"Ungvari","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.mehy.2004.08.031_bib126","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/ndt\/gfh270","article-title":"Homocysteine induced impairment of nitric oxide-dependent vasorelaxation is reversible by the superoxide dismutase mimetic TEMPOL","volume":"19","author":"Hucks","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.mehy.2004.08.031_bib127","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.bjp.0702374","article-title":"Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta","volume":"126","author":"Emsley","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.mehy.2004.08.031_bib128","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1464-410x.1999.00253.x","article-title":"The interaction of homocysteine and copper markedly inhibits the relaxation of rabbit corpus cavernosum: new risk factors for angiopathic erectile dysfunction","volume":"84","author":"Khan","year":"1999","journal-title":"BJU Int"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T11:59:59Z","timestamp":1549195199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987705000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0306987705000691"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.08.031","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}